Here is some information about ALBT's previous earnings and news:
- Earnings History: Avalon GloboCare (ALBT) reported a loss of -$0.02 for the quarter ending March 31, 2024, with a revenue of $317.4K1. For the quarter ending June 30, 2023, the company reported a loss of -$0.02 with a revenue of $290.8K1. It's important to note that these figures are from the previous year and may not reflect the current financial performance.
- News: Avalon GloboCare has been involved in several news and developments. The company announced the launch of U.S. sales of its KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 Conference2. Additionally, Avalon GloboCare extended its exclusivity agreement to distribute the KetoAir Breathalyzer Device and AI-Enabled Software in various regions2. These developments could potentially impact the company's future earnings.
In conclusion, while ALBT has reported losses in the past, the company has also been actively pursuing new product launches and distribution agreements, which could contribute to future earnings potential. Investors should consider these factors along with any upcoming earnings reports and market conditions when evaluating the stock's potential for breakout performance.